Inside Innovation

A new life science building is set to be built in Seattle’s Interbay neighborhood, overlooking Terminal 86 and shouldering Expedia’s headquarters. The building is nearly

Bothell-based biotech company Seagen found success with one of its breast cancer therapies on Wednesday. A combination of the treatment, named Tuksya, met the goal

AGC Biologics, a biotech company headquartered in Bothell, is partnering with pharmaceutical company Asahi Kasei to develop a drug substance that will support antibody therapies.

Absci, a biotech firm based in Vancouver, Washington, received a grant from the Bill & Melinda Gates Foundation to fund its partnership with the California

Seattle biotech company Cocrystal Pharma received permission from regulators to begin early-stage clinical trials for its COVID-19 and norovirus treatments. Previously, the company focused on

Access to Advanced Health Institute, a biotech nonprofit based in Seattle, received an $18 million grant from the National Institutes of Health. The funding will

Washington’s labor market has remained strong amidst national tech layoffs and indicators of a recession. According to the Bureau of Labor Statistics, high hiring rates

Phase Genomics, a Seattle-based biotech company, secured $2.5 million in funding from the National Cancer Institute and the Andy Hill Cancer Research Endowment (CARE) Fund

Seattle is ranked ninth in GEN’s 2023 rankings for the top 10 biopharma clusters across the country. Over the past year, major biotech moves including

Dexter Yard, a new, two-tower complex in Seattle, is becoming a home for several biotech companies moving into the space. Outpace Bio, Parse Biosciences and

Sana Biotechnology Inc., a biotech company based in Seattle, broke ground on its new Bothell manufacturing site recently. The 80,000 square-foot facility, which will provide